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Abstract The goal of this study was to evaluate the efficacy of Alpha ointment in
the treatment of burn wounds and compare its results with silver sulfadiazine (SS).
Similar burn ulcers were produced on anterior surface of thigh of 60 rats. The
wounds were infected with Pseudomonas aeruginosa and dressing and debridement
was performed daily. The first group of rats received topical SS, the second group
received Alpha ointment and the third (control group) received no medication.
Wound healing, contraction, culture, and scar formation were evaluated at the
end of the second and 10th week. Alpha ointment was equally effective as SS,
considering wound healing and contraction. Wound infection was significantly less
common in Alpha ointment group compared to the other two groups (p< 0.05).
Alpha ointment is a less expensive drug with an acceptable result compared to
SS. Therefore, we recommend it as an alternative to SS, especially in patients with
low economical backgrounds or in those who show adverse reactions to SS.
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3rd Degree burns, which are the most severe form
of burn, usually need dressing with appropriate
medications in order to prevent infection.1e3 ThisPublished by Elsevier Ltd. All rights reserved.
24 S.V. Hosseini et al.topical treatment should reduce bacterial prolifer-
ation, most commonly caused by Pseudomonas spe-
cies, and prevent resistant sepsis.4,5 Several groups
of topical medications and antibiotics have been
used in the treatment of wound infection of burn
ulcers, e.g. mefenamide, silver sulfadiazine, neo-
mycine, polymyxine B, etc.4,6,7 Silver sulfadiazine,
one of the most commonly used topical antibiotics,
is effective in the treatment of common bacterial
wound infections, including Pseudomonas and Pro-
teus infections.8,9 It significantly reduces the time
needed for the treatment of deep burn wounds.10
However, it still carries a high risk of resistance
and may cause transient leukopenia secondary to
bone marrow suppression.2
Concerns on problems such as high cost of
treatment, increasing resistance to antibiotics,
and inability to restore initial appearance of skin
resulted in researches on newer agents for the
treatment of burn wounds.2 Alpha is an ointment
with active ingredient of Lawsone, available in
Lawsonia inermis plant (from henna Lythraceae
intermis). This ointment used in 30-g packages in
Iran is cheaper (approximately one-fourth the
cost of SS) than other topical antibiotics and has
very few acceptable adverse reactions.11,12 The
aim of this study was to examine the efficacy of
Alpha ointment as a bactericidal agent, its ability
of wound healing and compare it with silver sulfa-
diazine ointment in the treatment of burn wounds
in rats as an experimental model.
Methods
In a randomized clinical trial, 60 rats with equal
mean weights were divided into three equal
groups. A standard 3rd degree burn wound was
produced on the anterior surface of thigh of the
rats under general anesthesia with ether. The burn
wound was induced after shaving the area with
a hot plate with same size (1 1.5 cm) and at an
equal temperature (heated up to 156 F or 69 C
and placed for 3 s on the skin).13 Each rat was
placed in an isolated cage to inhibit transmission
of infection. The wounds were examined after
24 h and if necrotic tissue was observed, it was re-
moved. Debridement procedure in the standard
way was done for all the animals. Then the wounds
were inoculated with Pseudomonas aeruginosa. All
of the rats were infected at the same time with
the same samples. Weight of the rats were mea-
sured in the beginning of the study and on one,
two and 10 weeks thereafter.
This study was approved by the ethical commit-
tee of Shiraz University of Medical Sciences and thePrinciples of laboratory animal care (NIH publica-
tion No. 86-23, revised 1985) were followed.
Exotoxin-A producing P. aeruginosa species were
obtained from the infected wounds of patients who
were admitted to the burn department of Ghotb-
el-din Hospital, a burn care-center affiliated to
Shiraz University of Medical Sciences. Cultures of
these infected wounds were documented as posi-
tive with P. aeruginosa. The species were cultured
in blood agar medium and incubated at 37 C for
48 h. Some laboratory tests such as TSI, oxidase
and citrate were performed to confirm the bacte-
rial species. To determine the exotoxin-A produc-
ing properties of P. aeruginosa they were cultured
in liquid medium and then centrifuged and the
supernatant was concentrated 20 times. Then the
Ouchterlony test was performed to confirm
the exotoxin producing properties of the species.
The number of bacteria in each tube was adjusted
to 0.5 McFarland (equal to 1.5 108 bacteria/cm3).
Each rat received injection of the bacterial prepa-
ration in volume equal to 15 106 bacteria. The
bacterial species were injected subcutaneously
into the burn wound. Twenty-four hours after the
injection, wounds of the first group were dressed
with silver sulfadiazine ointment (Sina Daru, Teh-
ran, Iran). In the second group the ulcers were
dressed with Alpha ointment (Sina Daru, Tehran,
Iran), and in the third group, no ointment was uti-
lized. The dressings were changed daily and de-
bridement was performed if needed in all the
groups in a similar manner.
Clinical evaluation of the wound, including size,
existence of satellite lesions, contraction of the
wounds, and crust formation, was performed on
the second and 10th week. The wounds were
classified according to their characteristics (grade
1: clean; grade 2: color change; grade 3: color
change and nodules around the wound; and grade
4: clear pussy discharge). In addition to the clinical
evaluation, the wounds were cultured in blood
agar medium and placed in a 37 C incubator. They
were checked after 48 h for the presence of
P. aeruginosa using different laboratory tests.
The obtained data were analyzed by SPSS Win
10.0 software. Student t-test, Chi-square, and AN-
OVA test were used to compare the study groups
and the significance level was determined as less
than 0.05.
Results
Results of wound grading among the different
groups of rats at the end of the second week are
shown in Table 1. Alpha ointment significantly
Alpha ointment in 3rd degree burns 25Table 1 Grading of the wounds, scar formation, positive culture and contracture of the studied rats in the three
groups after two and 10 weeks
SS Alpha p-Value* Control p-Value**
Second week Grade 1, n (%) 4 (20) 4 (20) NS 1 (5) <0.05
Grade 2, n (%) 7 (35) 12 (60) <0.05 4 (20) <0.05
Grade 3, n (%) 5 (25) 1 (5) <0.05 0 (0) <0.05
Grade 4, n (%) 4 (20) 3 (15) NS 15 (75) <0.05
Positive culture 5 (25) 4 (20) NS 8 (40) <0.05
10th Week Grade 1, n (%) 11 (55) 14 (70) NS 9 (45) <0.05
Grade 2, n (%) 1 (5) 2 (10) NS 2 (10) NS
Grade 3, n (%) 0 (0) 0 (0) NS 0 (0) NS
Grade 4, n (%) 8 (40) 4 (20) <0.05 9 (45) <0.05
Scar formation 6 (30) 8 (39) NS 5 (26) <0.05
Contracture 15 (75) 20 (100) <0.05 19 (95) NS
The data are presented in percentage. SS: silver sulfadiazine; NS: not significant; *Comparison between SS group and Alpha group;
**Comparison between the rats receiving Alpha ointment and control group.
Classification of the wounds: grade 1: clean; grade 2: color change; grade 3: color change and nodules around the wound; and
grade 4: clear pussy discharge.decreased the rate of wound infection, positive
culture and scar formation compared to control
group (p< 0.05) (Table 1). A decrease in weight
was observed in the first week and an increase in
the second week. Weight was similar in all the
three groups. Compared to SS group, Alpha oint-
ment group revealed similar results concerning
wound infection, positive culture and scar forma-
tion. However, contraction was significantly less
common in the SS group compared to the control
and Alpha ointment groups (p< 0.05) (Table 1).
Among the studied rats, two rats in the second
group and one in the third group died. Grading of
the wounds, scar formation, positive culture rate
and contracture rate of the studied rats in all the
three groups after two and 10 weeks are shown in
Table 1.
Discussion
In this study Alpha ointment group revealed similar
therapeutic and prevention results compared to
silver sulfadiazine. A wide variety of substances
have been reported to be useful in the treatment
of infected burn wounds, e.g. topical phenytoin,14
honey,15,16 proflavine,17 etc. Among the different
topical medications, mefenamide is one of the
most commonly studied ointments that had some
advantages over the other drugs. Unfortunately,
this drug was excluded from the market because
of its frequent side effects. Silver sulfadiazine is
a topical antibacterial ointment that is used widely
for the prevention and treatment of burn wounds17
and must be used every 24 h to be effective.18 This
ointment can penetrate into scars and hasantimicrobial effects.19 It has been reported that
this ointment is effective in treating Pseudomonas
infections.20
Henna leaf (L. inermis) is commonly known as
Hanna in Iran and Mehndi in India. It is a very po-
pular natural dye to color hand and hair and is an
integral part of indigenous culture. It does not
permanently dye hair and hands when used right
on the very outer layer of the skin, but it might
result in a permanent tattoo-like effect in deeper
uses. Henna is also known for its medicinal values.
Alpha ointment is a new pharmacological prepara-
tion in Iran that in traditional medicine has been
used in skin diseases, boils, burning sensation in
feet and burns.21 Although it has been used in
some burn centers its efficacy in treating wound
infection or repair has not been systematically stud-
ied. Additionally, there have been only a few
studies on Alpha drug and its efficacy in the treat-
ment and prevention of wound infection in burn
patients.21 We observed that this ointment (and
its effective component L. inermis) effectively
stopped bacterial growth and induced healing of
burn wounds comparable to SS. In a study per-
formed by Habbal et al. the antimicrobial activity
of henna’s fresh and dry leaves and seeds obtained
from Oman against three standard bacterial strains
namely Staphylococcus aureus, Escherichia coli and
P. aeruginosawas evaluated. They observed that all
fresh and dry leaves and seeds of the Omani henna
demonstrated antibacterial activity against all the
three standard strains.22 On each episode of de-
bridement and dressing, approximately 5 g of Alpha
ointment is needed for every 1% of 3rd degree
burned body surface area. As for SS, 10 g is needed
for the same percent, degree and body surface
26 S.V. Hosseini et al.area. Fifty grams of Alpha ointment costs 2500 Rials
(equivalent to 0.28$). However, 50 g of SS costs
5000 Rials (equivalent to 0.56$). Therefore, the
cost of Alpha ointment is approximately one-fourth
of SS and is economically beneficial, especially in
our setting and also in other developing countries
with a low socio-economical status.
Catania and King presented the results of an in
vivo evaluation of silver sulfadiazine dry foam.
Using burned guinea pigs infected with P. aerugi-
nosa, they applied SS on the infected wound and
concluded that SS had significant anti-P. aerugi-
nosa properties.20 In our study we proved that
Alpha ointment has anti-P. aeruginosa properties
similar to SS and therefore, may be used as an
alternative drug with similar results.
In the third group in which no ointments were
used, the results of wound healing and contraction
were similar to the other two groups. Therefore, it
can be concluded that daily debridement and
change of dressing with irrigation is equally effec-
tive in the treatment of burn wound and prevent-
ing scar and functional disabilities.
Considering these results, it can be concluded
that Alpha ointment may be a suitable alternative
for SS. Additionally this ointment is more economi-
cal. It is suggested that further studies are to be done
with larger sample sizes on human cases for a lon-
ger study period to thoroughly evaluate the efficacy
of Alpha ointment on burn wounds in human.
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